Canopy Growth Corp T.WEED

Alternate Symbol(s): T.WEED.DB | CGC

Healthcare Cannabis

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.

TSX:WEED - Post by User

Canopy Growth Corp > Warning sign

<< Previous

Bullboard Posts

Next >>

Comment by Newbie420on Apr 08, 2022 9:53am

128 Views

Post# 34587494

RE:Warning sign

Bio-steel is non-cannabis Starsearcher. There are more but I won't do the DD for you. Just wanted to point out how uninformed you are.

lou64 wrote:
Hate to be the bearer of bad news but Tilray just provided guidance into Canopy's next coming earnings ... Tilray LOST more market share in Canada and sold less pot in Canadian market place meaning Craft Producers are killing it !!!

Tilray was saved only because of International Med sales and non - cannabis but Canopy sold off interest in International market and has no non- cannabis business

Expect another hit !!! Like it or not them are the warning signs

https://finance.yahoo.com/news/tilray-stock-increasing-profitability-still-185841959.html
In a market which saw a 5% downturn, recreational sales dropped by 12% quarter-over-quarter and medical declined by 11%. The company grew its share of vapes and pre-rolls in the Canada rec segment, but the overall share loss was mostly on account of an oversupplied market – particularly in the flower segment.